DISCOUNT ZERTIFIKAT - AMGEN | Real-time Bid/Ask 04:49:42 2024-07-16 am EDT | ||
| 269.73 EUR / 271.24 EUR | -0.01% |
|
| Current month | +0.30% | ||
| 1 month | +2.05% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-15 | 270.5 | +0.06% |
| 24-07-12 | 270.4 | +0.10% |
| 24-07-11 | 270.1 | +0.02% |
| 24-07-10 | 270 | +0.52% |
| 24-07-09 | 268.6 | +0.29% |
Delayed Quote Börse Stuttgart
Last update July 15, 2024 at 03:09 pm EDT
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME680V |
| ISIN | DE000ME680V6 |
| Date issued | 2024-01-02 |
| Maturity | 2024-09-20 (67 Days) |
| Parity | 1 : 1 |
| Emission price | 243 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 273.1 € |
|---|---|
| Lowest since issue | 235.7 € |
| Spread | 1.23 € |
| Spread % | 0.45% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.2
USD
Average target price
317.4
USD
Spread / Average Target
-3.86%
- Stock Market
- Certificates
- Certificat
